Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling

Surgical Endoscopy

Volumn 23, Issue 6, 2009, Pages 1346-1352

  Oh, Daniel S ^a   DeMeester, Steven R ^b   Dunst, Christy M ^a   Mori, Ryutaro ^b   Lehman, Bethany J ^a   Kuramochi, Hidekazu ^b   Danenberg, Kathleen ^c   Danenberg, Peter ^b   Hagen, Jeffrey A ^a   Chandrasoma, Parakrama ^b   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Response Genetics Inc   (United States)

Author keywords

Barrett's esophagus; Esophageal cancer; Esophagus; GERD

Indexed keywords

MESSENGER RNA; TREFOIL PEPTIDE; TREFOIL PEPTIDE 1; TREFOIL PEPTIDE 2; TREFOIL PEPTIDE 3; UNCLASSIFIED DRUG; NEUROPEPTIDE; PEPTIDE; TFF1 PROTEIN, MOUSE; TFF3 PROTEIN, RAT; TREFOIL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; BIOLOGICAL MODEL; CONTROLLED STUDY; ESOPHAGOJEJUNOSTOMY; GENE EXPRESSION; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; VALIDATION STUDY; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; ESOPHAGUS; GENE EXPRESSION REGULATION; GENETICS; JEJUNUM; METABOLISM; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BARRETT ESOPHAGUS; DISEASE MODELS, ANIMAL; ESOPHAGUS; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; JEJUNUM; MALE; NEUROPEPTIDES; PEPTIDES; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 68849111417     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-008-0169-5     Document Type: Article

References (34)

1. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97(2):142-146
2. Kubo A, Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99(4):582-588
3. van Blankenstein M, Looman CWN, Johnston BJ, Caygill CPJ (2005) Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol 100(3):568-576
4. van Soest EM, Dieleman JP, Siersema PD et al (2005) Increasing incidence of Barrett's oesophagus in the general population. Gut 54(8):1062-1066
5. Oberg S, Johansson J, Wenner J, Walther B (2002) Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 235(3):338-345
6. Theisen J, Nigro JJ, DeMeester TR et al (2004) Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence. Dis Esophag 17(1):67-70
7. Miwa K, Sahara H, Segawa M et al (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67(2):269-274
8. Attwood SE, Smyrk TC, DeMeester TR et al (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111(5):503-510
9. Ireland AP, Peters JH, Smyrk TC et al (1996) Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg 224(3):358-370, discussion 370-371
10. Fein M, Peters JH, Chandrasoma P et al (1998) Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2(3):260-268
11. Nishijima K, Miwa K, Miyashita T et al (2004) Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240(1):57-67
12. Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CB, DeMeester TR (1997) Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1:27-33
13. Sato T, Miwa K, Sahara H et al (2002) The sequential model of Barrett's esophagus and adenocarcinoma induced by duodenoesophageal reflux without exogenous carcinogens. Anticancer Res 22(1A):39-44
14. Goldstein SR, Yang GY, Curtis SK et al (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 18(11):2265-2270
15. Bonner RF, Emmert-Buck M, Cole K et al (1997) Laser capture microdissection: molecular analysis of tissue. Science 278(5342):1481,1483
16. Vallbohmer D, Peters JH, Oh D et al (2005) Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery 138(4):701-706, discussion 706-707
17. Levrat M, Lambert R, Kirshbaum G (1962) Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis 7(6):564-573
18. Mirvish SS, Huang Q, Chen SC et al (1993) Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 25(9):627-631
19. Clark GW, Smyrk TC, Mirvish SS et al (1994) Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1(3):252-261
20. Oberg S, Lord RV, Peters JH et al (2000) Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? J Surg Res 91(2):111-117
21. Pera M, Pera M (2002) Experimental Barrett's esophagus and the origin of intestinal metaplasia. Chest Surg Clin North Am 12(1):25-37
22. Kumagai H, Mukaisho K, Sugihara H et al (2003) Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model. Scand J Gastroenterol 38(7):687-692
23. Buskens CJ, Hulscher JBF, van Gulik TM et al (2006) Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res 135(2):337-344
24. Warson C, Van De Bovenkamp JHB, Korteland-Van Male AM et al (2002) Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Human Pathol 33(6):660-668
25. DeMeester SR, DeMeester TR (2000) Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 231(3):303-321
26. Oh DS, Hagen JA, Fein M et al (2006) Impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 10(6):787-797
27. Campos GM, DeMeester SR, Peters JH et al (2001) Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 136(11):1267-1273
28. Barley NF, Taylor V, Shaw-Smith CJ et al (2003) Human ileal bile acid-binding protein promoter and the effects of CDX2. Biochim Biophys Acta 1630(2-3):138-143
29. Kazumori H, Ishihara S, Rumi MAK et al (2006) Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 55(1):16-25
30. Hu Y, Williams VA, Gellersen O et al (2007) The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells. J Gastrointest Surg 11(7):827-834
31. Hu Y, Jones C, Gellersen O et al (2007) Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg 142(6):540-544, discussion 544-545
32. Shimada H, Koike T, Yamagata M, Yoneda M, Hiraishi H (2007) Regulation of TFF3 expression by homeodomain protein CDX2. Regulat Peptides 140:81-87
33. Baus-Loncar M, Giraud AS (2005) Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Molec Life Sci 62(24): 2921-2931
34. Emami S, Rodrigues S, Rodrigue CM et al (2004) Trefoil factor family (TFF) peptides and cancer progression. Peptides 25(5):885-898